Objectives

After participating in this educational activity, attendees should be able to:

1|Describe surgical approaches to treatment for severe to profound hearing loss 
2|Discuss indications for gene therapy for hearing loss

Presenter 
Aiden Eliot Shearer, MD, PhD
Assistant Professor of Otolaryngology Head & Neck Surgery
Harvard Medical School

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Aiden Eliot Shearer, MD, PhD
Speaker

Funding: National Institute of Deafness and Communication Disorders, Escuchar Sin Fronteras, Boston Children's Translational Research Program, Usher Syndrome Society 
Principal Investigator: Investigator Initiated Clinical Trial, Genetic Newborn Hearing Screening, Eli Lilly 
Site Principal Investigator: Sponsored Phase I/II clinical trial OTOF gene therapy, Akouos/Eli Lilly; Sponsored Phase I/II clinical trial OTOF gene therapy, Decibel/Regeneron 
Scientific Advisory Board: Eli Lilly and Regeneron

No
    
Session date: 
04/02/2026 - 8:00am to 9:00am EDT
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut 1A&B
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 American Board of Surgery MOC
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.